Tenders of Kkh Kaufm Nnische Krankenkasse

Tenders of Kkh Kaufm Nnische Krankenkasse

KKH Kaufm Nnische Krankenkasse - KKH Tender

Healthcare and Medicine
Germany
Closing Date30 Jun 2025
Tender AmountRefer Documents 
Germany-hanover: Pharmaceutical Products

KKH Kaufm Nnische Krankenkasse - KKH Tender

Healthcare and Medicine
Germany
Closing Date30 Jun 2025
Tender AmountRefer Documents 
Germany-hanover: Pharmaceutical Products

KKH Kaufm Nnische Krankenkasse - KKH Tender

Healthcare and Medicine
Germany
Closing Date30 Jun 2025
Tender AmountRefer Documents 
Germany-hanover: Pharmaceutical Products

KKH Kaufm Nnische Krankenkasse - KKH Tender

Healthcare and Medicine
Germany
Closing Date31 May 2025
Tender AmountRefer Documents 
Germany-hanover: Pharmaceutical Products

KKH Kaufm Nnische Krankenkasse - KKH Tender

Others
Germany
Closing Date30 Jun 2025
Tender AmountRefer Documents 
Completion of non-exclusive discounts according to § 130a para. 8 Sgb W To The In Ii.2.4. Known active ingredients With the possibility of completing the so-called open-house process. (2023-26116-ohb-lapatinib)

KKH Kaufm Nnische Krankenkasse - KKH Tender

Healthcare and Medicine
Germany
Closing Date31 May 2025
Tender AmountRefer Documents 
Germany-hanover: Pharmaceutical Products

KKH Kaufm Nnische Krankenkasse - KKH Tender

Healthcare and Medicine
Germany
Closing Date31 May 2025
Tender AmountRefer Documents 
Germany-hanover: Pharmaceutical Products

KKH Kaufm Nnische Krankenkasse - KKH Tender

Healthcare and Medicine
Germany
Closing Date30 Jun 2025
Tender AmountRefer Documents 
Germany-hanover: Pharmaceutical Products

KKH Kaufm Nnische Krankenkasse - KKH Tender

Healthcare and Medicine
Germany
Closing Date30 Jun 2025
Tender AmountRefer Documents 
Germany-hanover: Pharmaceutical Products

KKH Kaufm Nnische Krankenkasse - KKH Tender

Others
Germany
Closing Date30 Jun 2025
Tender AmountRefer Documents 
Completion of non-exclusive discounts according to § 130a para. 8 Sgb W To The In Ii.2.4. Known active ingredients With the possibility of completing the so-called open-house process. (2023-24920-ohb-tranexamic acid Only Fta)
211-220 of 230 active Tenders